This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Runic, R. Articles by Lockwood, C. J. Search for Related Content PubMed PubMed Citation Articles by Runic, R. Articles by Lockwood, C. J.

Alterations in Endometrial Stromal Cell Tissue Factor Protein and Messenger Ribonucleic Acid Expression in Patients Experiencing Abnormal Uterine Bleeding While Using Norplant-2 Contraception¹

Radmila Runi, Frederick Schatz, Lewis Krey, Rita Demopoulos, Stephen Thung, Livia Wan and Charles J. Lockwood

Departments of Obstetrics and Gynecology (R.R., F.S., L.K., S.T., L.W., C.J.L.), Cell Biology (L.K.), and Pathology (R.D.), New York University School of Medicine, New York, New York 10016

Address all correspondence and requests for reprints to: Dr. Charles J. Lockwood, Department of Obstetrics and Gynecology, New York University School of Medicine, 550 First Avenue, New York, New York 10016.

A high incidence of irregular uterine bleeding is the primary patient complaint limiting the utility of long term, progestin-only contraceptive agents such as Norplant. The onset of hemorrhage requires both inadequate hemostasis and impaired vascular integrity. Thus, we first tested whether Norplant-associated endometrial bleeding was accompanied by altered expression of perivascular stromal cell tissue factor (TF), the primary initiator of hemostasis. Norplant effects on TF messenger ribonucleic acid (mRNA) and protein expression by endometrial stromal cells were assessed by in situ hybridization and immunohistochemical examination of endometrial biopsies obtained from normally cycling control women (n = 14) and from patients experiencing Norplant-induced abnormal uterine bleeding (n = 24). TF mRNA and protein expression was increased 150% in secretory vs. proliferative phase endometrial specimens. By contrast, endometrial TF mRNA and protein levels were reduced during 1–6 months of Norplant treatment by about 2-fold (P < 0.05 for protein) compared to the values for control secretory phase specimens. These changes were consistent with observations that patients on Norplant begin to bleed during this interval. Further reductions of TF mRNA and protein levels to 2- and 3-fold of those in secretory phase control specimens were observed in endometria obtained after 6–12 months of Norplant therapy (P < 0.05 and P < 0.01, respectively). A modest rebound in TF mRNA and protein expression was observed after 12 months of Norplant therapy, which occurred commensurate with reduced patient complaints of abnormal uterine bleeding. Pathologically enlarged venous sinusoids were ubiquitous in endometrial specimens obtained after Norplant therapy. The combination of fragile blood vessels and reduced TF expression may account for bleeding in patients receiving Norplant therapy.

This article has been cited by other articles:

				C. J. Lockwood, W. Murk, U. A. Kayisli, L. F. Buchwalder, S.-T. Huang, E. F. Funai, G. Krikun, and F. Schatz Progestin and Thrombin Regulate Tissue Factor Expression in Human Term Decidual Cells J. Clin. Endocrinol. Metab., June 1, 2009; 94(6): 2164 - 2170. [Abstract] [Full Text] [PDF]

				C. J. Lockwood, G. Krikun, M. Hickey, S. J. Huang, and F. Schatz Decidualized Human Endometrial Stromal Cells Mediate Hemostasis, Angiogenesis, and Abnormal Uterine Bleeding Reproductive Sciences, February 1, 2009; 16(2): 162 - 170. [Abstract] [PDF]

				N. B Morison, J. Zhang, T. J Kaitu'u-Lino, I. S Fraser, and L. A Salamonsen The long-term actions of etonogestrel and levonorgestrel on decidualized and non-decidualized endometrium in a mouse model mimic some effects of progestogen-only contraceptives in women Reproduction, January 1, 2007; 133(1): 309 - 321. [Abstract] [Full Text] [PDF]

				G. Krikun, F. Schatz, R. Taylor, H. O. D. Critchley, P. A. W. Rogers, J. Huang, and C. J. Lockwood Endometrial Endothelial Cell Steroid Receptor Expression and Steroid Effects on Gene Expression J. Clin. Endocrinol. Metab., March 1, 2005; 90(3): 1812 - 1818. [Abstract] [Full Text] [PDF]

				C. J. Lockwood, G. Krikun, A. B. C. Koo, S. Kadner, and F. Schatz Differential Effects of Thrombin and Hypoxia on Endometrial Stromal and Glandular Epithelial Cell Vascular Endothelial Growth Factor Expression J. Clin. Endocrinol. Metab., September 1, 2002; 87(9): 4280 - 4286. [Abstract] [Full Text] [PDF]

				C. Galant, M. Vekemans, P. Lemoine, I. Kokorine, P. Twagirayezu, P. Henriet, C. Picquet, V. Rigot, Y. Eeckhout, P. J. Courtoy, et al. Temporal and Spatial Association of Matrix Metalloproteinases with Focal Endometrial Breakdown and Bleeding upon Progestin-Only Contraception J. Clin. Endocrinol. Metab., December 1, 2000; 85(12): 4827 - 4834. [Abstract] [Full Text]

				R. Runic, F. Schatz, L. Wan, R. Demopoulos, G. Krikun, and C. J. Lockwood Effects of Norplant on Endometrial Tissue Factor Expression and Blood Vessel Structure J. Clin. Endocrinol. Metab., October 1, 2000; 85(10): 3853 - 3859. [Abstract] [Full Text]

				C. J. Lockwood, G. Krikun, R. Runic, L. B. Schwartz, A. F. Mesia, and F. Schatz Progestin-Epidermal Growth Factor Regulation of Tissue Factor Expression during Decidualization of Human Endometrial Stromal Cells J. Clin. Endocrinol. Metab., January 1, 2000; 85(1): 297 - 301. [Abstract] [Full Text]